Literature DB >> 2926867

Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication.

A Géssner1, H Lother.   

Abstract

Depending on the multiplicity of infection (MOI), infection of L929 cells results in either productive lymphocytic choriomeningitis virus replication or homologous interference M. Bruns, A. Gessner, H. Lother, and F. Lehmann-Grube, Virology 166:133-139, 1988). As shown in this communication, productive lymphocytic choriomeningitis virus replication as observed at a low MOI was effectively inhibited by ribavirin. In contrast, virus yields increased if cells were infected with a high MOI and in the presence of 5 microM of the antiviral compound. This drug-dependent release of infectious virus was preceded by enhanced nucleoprotein (NP) synthesis, a change in intracellular NP distribution, and by an onset of glycoprotein synthesis. It is therefore proposed that this block in viral replication is brought about by a posttranslational effect on a viral gene product, probably the NP, present in reasonably large quantities both during homologous interference as well as persistent infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926867      PMCID: PMC248467          DOI: 10.1128/JVI.63.4.1827-1832.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  State of viral genome and proteins during persistent lymphocytic choriomeningitis virus infection.

Authors:  S J Francis; P J Southern; A Valsamakis; M B Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

Review 2.  Arenavirus gene structure and organization.

Authors:  D H Bishop; D D Auperin
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

3.  Experimental studies of arenaviral hemorrhagic fevers.

Authors:  C J Peters; P B Jahrling; C T Liu; R H Kenyon; K T McKee; J G Barrera Oro
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

Review 4.  Pathology and pathogenesis of arenavirus infections.

Authors:  D H Walker; F A Murphy
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

Review 5.  Ambisense RNA genomes of arenaviruses and phleboviruses.

Authors:  D H Bishop
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

Review 6.  Protein serine/threonine kinases.

Authors:  A M Edelman; D K Blumenthal; E G Krebs
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Immunotherapy for virus infection.

Authors:  M B Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

Review 8.  Protein structure and expression among arenaviruses.

Authors:  M J Buchmeier; B S Parekh
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

9.  Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus.

Authors:  M K Singh; F V Fuller-Pace; M J Buchmeier; P J Southern
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

Review 10.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

View more
  6 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  Shenghua Zhou; Anna M Cerny; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection.

Authors:  David G Brooks; Dorian B McGavern; Michael B A Oldstone
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

4.  HLA-A2-restricted protection against lethal lymphocytic choriomeningitis.

Authors:  Jason Botten; J Lindsay Whitton; Polly Barrowman; John Sidney; Jason K Whitmire; Jeff Alexander; Joey P C Ting; Huynh-Hoa Bui; Alessandro Sette; Michael J Buchmeier
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

5.  Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.

Authors:  Eugene J Gillespie; Chi-Lee C Ho; Kavitha Balaji; Daniel L Clemens; Gang Deng; Yao E Wang; Heidi J Elsaesser; Batcha Tamilselvam; Amandeep Gargi; Shandee D Dixon; Bryan France; Brian T Chamberlain; Steven R Blanke; Genhong Cheng; Juan Carlos de la Torre; David G Brooks; Michael E Jung; John Colicelli; Robert Damoiseaux; Kenneth A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

6.  Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes.

Authors:  Nadine Honke; Namir Shaabani; Dong-Er Zhang; George Iliakis; Haifeng C Xu; Dieter Häussinger; Mike Recher; Max Löhning; Philipp A Lang; Karl S Lang
Journal:  PLoS Pathog       Date:  2013-10-24       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.